Thomas J. Schall, President and CEO at ChemoCentryx, Inc. (CCXI), sold 7,211 shares at $12.00 ($87K) on 2018-11-07, disclosed to the SEC on 2018-11-09.
Open-market sale of $87k CCXI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IMRX | BUY | 2025-06-18 | $179K | — | Filing → |
| IMRX | BUY | 2024-03-25 | $7K | — | Filing → |
| CCXI | SELL | 2022-08-08 | $6.5M | — | Filing → |